Learn / BIO
NYSE: BIO
Bio Rad Laboratories (BIO) stock, explained like you're 5
Bio Rad Laboratories trades on the New York Stock Exchange under the ticker BIO. It is a mid cap company in the laboratory analytical instruments industry, part of the healthcare sector, with a market value of about 9.8 billion dollars.
- Ticker
- BIO
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Laboratory Analytical Instruments
- Size
- Mid cap, about 9.8 billion dollars
Is Bio Rad Laboratories a small, medium or large cap company?
No. Bio Rad Laboratories is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 9.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Bio Rad Laboratories makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BIO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Bio Rad Laboratories, Inc. (BIO) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- How Investors Are Reacting To Bio Rad Laboratories Stock Vericheck Kit Expansion (Simply Wall Street)
- Gossamer Bio Stock Plummeted 82% Today What’s Behind The Crash? (Stocktwits)
- A 2 p.m. Pacific call is scheduled to discuss Bio Rad's third quarter results Nov. 4. (Stock Titan)
- Zura Bio presents trial poster. Guggenheim targets Zura Bio stock at USD 20 (ad-hoc-news.de)
Follow BIO in your daily brief
Each trading day at 5 PM ET we post what happened to Bio Rad Laboratories and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BIO
Questions about Bio Rad Laboratories stock
What does Bio Rad Laboratories do?
Bio Rad Laboratories trades on the New York Stock Exchange under the ticker BIO. It is a mid cap company in the laboratory analytical instruments industry, part of the healthcare sector, with a market value of about 9.8 billion dollars.
What is the ticker symbol for Bio Rad Laboratories?
Bio Rad Laboratories trades under the ticker BIO on the New York Stock Exchange.
What is Bio Rad Laboratories's market cap?
Bio Rad Laboratories is a mid cap stock with a market cap of about 9.8 billion dollars.
How does Bio Rad Laboratories make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BIO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BIO stock every day?
Add BIO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.